KA
ADNT icon

Kozak & Associates’s Adient ADNT Stock Holding History

Kozak & Associates’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-203
Closed -$6.64K – 401
2023
Q4 		$6.64K Hold
203
– – ﹤0.01% 261
2023
Q3 		$7.29K Hold
203
– – ﹤0.01% 264
2023
Q2 		$7.92K Hold
203
– – ﹤0.01% 249
2023
Q1 		$8.31K Buy
+203
New +$8.48K ﹤0.01% 242

Other funds holding ADNT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kozak & Associates's ADNT Position: Q1 2024 in Review

Kozak & Associates sold out of Adient (ADNT) in Q1 2024, closing a stake of 203 shares — an estimated $6.64K sold.

Kozak & Associates first reported a position in ADNT in Q1 2023 and held it in 4 quarters. The position peaked at $8.31K in Q1 2023. 311 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

  • Kozak & Associates reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
  • Kozak & Associates sold 203 Adient shares in Q1 2024, an estimated $6.64K.
  • Kozak & Associates first reported a position in Adient in Q1 2023 and held it in 4 quarters.
  • Kozak & Associates's Adient position peaked at $8.31K in Q1 2023.
  • 311 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on Kozak & Associates's 13F filing for Q1 2024, filed 17 May 2024.